Global Mucopolysaccharidosis II Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Mucopolysaccharidosis II

• 1.1 Definition of Mucopolysaccharidosis II
• 1.2 Mucopolysaccharidosis II Segment by Type
  • 1.2.1 Global Mucopolysaccharidosis II Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 JR-141
  • 1.2.3 EGT-301
  • 1.2.4 DUOC-01
  • 1.2.5 AGT-182
  • 1.2.6 JR-032
  • 1.2.7 Others
• 1.3 Mucopolysaccharidosis II Segment by Applications
  • 1.3.1 Global Mucopolysaccharidosis II Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Research Center
  • 1.3.5 Others
• 1.4 Global Mucopolysaccharidosis II Overall Market
  • 1.4.1 Global Mucopolysaccharidosis II Revenue (2014-2025)
  • 1.4.2 Global Mucopolysaccharidosis II Production (2014-2025)
  • 1.4.3 North America Mucopolysaccharidosis II Status and Prospect (2014-2025)
  • 1.4.4 Europe Mucopolysaccharidosis II Status and Prospect (2014-2025)
  • 1.4.5 China Mucopolysaccharidosis II Status and Prospect (2014-2025)
  • 1.4.6 Japan Mucopolysaccharidosis II Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Mucopolysaccharidosis II Status and Prospect (2014-2025)
  • 1.4.8 India Mucopolysaccharidosis II Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Mucopolysaccharidosis II
• 2.3 Manufacturing Process Analysis of Mucopolysaccharidosis II
• 2.4 Industry Chain Structure of Mucopolysaccharidosis II

3 Development and Manufacturing Plants Analysis of Mucopolysaccharidosis II

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Mucopolysaccharidosis II Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Mucopolysaccharidosis II
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Mucopolysaccharidosis II Production and Capacity Analysis
• 4.2 Mucopolysaccharidosis II Revenue Analysis
• 4.3 Mucopolysaccharidosis II Price Analysis
• 4.4 Market Concentration Degree

5 Mucopolysaccharidosis II Regional Market Analysis

• 5.1 Mucopolysaccharidosis II Production by Regions
  • 5.1.1 Global Mucopolysaccharidosis II Production by Regions
  • 5.1.2 Global Mucopolysaccharidosis II Revenue by Regions
• 5.2 Mucopolysaccharidosis II Consumption by Regions
• 5.3 North America Mucopolysaccharidosis II Market Analysis
  • 5.3.1 North America Mucopolysaccharidosis II Production
  • 5.3.2 North America Mucopolysaccharidosis II Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Mucopolysaccharidosis II Import and Export
• 5.4 Europe Mucopolysaccharidosis II Market Analysis
  • 5.4.1 Europe Mucopolysaccharidosis II Production
  • 5.4.2 Europe Mucopolysaccharidosis II Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Mucopolysaccharidosis II Import and Export
• 5.5 China Mucopolysaccharidosis II Market Analysis
  • 5.5.1 China Mucopolysaccharidosis II Production
  • 5.5.2 China Mucopolysaccharidosis II Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Mucopolysaccharidosis II Import and Export
• 5.6 Japan Mucopolysaccharidosis II Market Analysis
  • 5.6.1 Japan Mucopolysaccharidosis II Production
  • 5.6.2 Japan Mucopolysaccharidosis II Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Mucopolysaccharidosis II Import and Export
• 5.7 Southeast Asia Mucopolysaccharidosis II Market Analysis
  • 5.7.1 Southeast Asia Mucopolysaccharidosis II Production
  • 5.7.2 Southeast Asia Mucopolysaccharidosis II Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Mucopolysaccharidosis II Import and Export
• 5.8 India Mucopolysaccharidosis II Market Analysis
  • 5.8.1 India Mucopolysaccharidosis II Production
  • 5.8.2 India Mucopolysaccharidosis II Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Mucopolysaccharidosis II Import and Export

6 Mucopolysaccharidosis II Segment Market Analysis (by Type)

• 6.1 Global Mucopolysaccharidosis II Production by Type
• 6.2 Global Mucopolysaccharidosis II Revenue by Type
• 6.3 Mucopolysaccharidosis II Price by Type

7 Mucopolysaccharidosis II Segment Market Analysis (by Application)

• 7.1 Global Mucopolysaccharidosis II Consumption by Application
• 7.2 Global Mucopolysaccharidosis II Consumption Market Share by Application (2014-2019)

8 Mucopolysaccharidosis II Major Manufacturers Analysis

• 8.1 Alexion Pharmaceuticals, Inc.
  • 8.1.1 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.1.2 Alexion Pharmaceuticals, Inc. Product Introduction, Application and Specification
  • 8.1.3 Alexion Pharmaceuticals, Inc. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 AngioChem Inc.
  • 8.2.1 AngioChem Inc. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.2.2 AngioChem Inc. Product Introduction, Application and Specification
  • 8.2.3 AngioChem Inc. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 ArmaGen Inc.
  • 8.3.1 ArmaGen Inc. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.3.2 ArmaGen Inc. Product Introduction, Application and Specification
  • 8.3.3 ArmaGen Inc. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Bioasis Technologies Inc.
  • 8.4.1 Bioasis Technologies Inc. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.4.2 Bioasis Technologies Inc. Product Introduction, Application and Specification
  • 8.4.3 Bioasis Technologies Inc. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Green Cross Corporation
  • 8.5.1 Green Cross Corporation Mucopolysaccharidosis II Production Sites and Area Served
  • 8.5.2 Green Cross Corporation Product Introduction, Application and Specification
  • 8.5.3 Green Cross Corporation Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Inventiva
  • 8.6.1 Inventiva Mucopolysaccharidosis II Production Sites and Area Served
  • 8.6.2 Inventiva Product Introduction, Application and Specification
  • 8.6.3 Inventiva Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 JCR Pharmaceuticals Co., Ltd.
  • 8.7.1 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.7.2 JCR Pharmaceuticals Co., Ltd. Product Introduction, Application and Specification
  • 8.7.3 JCR Pharmaceuticals Co., Ltd. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Laboratorios Del Dr. Esteve S.A.
  • 8.8.1 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.8.2 Laboratorios Del Dr. Esteve S.A. Product Introduction, Application and Specification
  • 8.8.3 Laboratorios Del Dr. Esteve S.A. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 RegenxBio Inc.
  • 8.9.1 RegenxBio Inc. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.9.2 RegenxBio Inc. Product Introduction, Application and Specification
  • 8.9.3 RegenxBio Inc. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Sangamo BioSciences, Inc.
  • 8.10.1 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Production Sites and Area Served
  • 8.10.2 Sangamo BioSciences, Inc. Product Introduction, Application and Specification
  • 8.10.3 Sangamo BioSciences, Inc. Mucopolysaccharidosis II Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Shire Plc

9 Development Trend of Analysis of Mucopolysaccharidosis II Market

• 9.1 Global Mucopolysaccharidosis II Market Trend Analysis
  • 9.1.1 Global Mucopolysaccharidosis II Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Mucopolysaccharidosis II Regional Market Trend
  • 9.2.1 North America Mucopolysaccharidosis II Forecast 2019-2025
  • 9.2.2 Europe Mucopolysaccharidosis II Forecast 2019-2025
  • 9.2.3 China Mucopolysaccharidosis II Forecast 2019-2025
  • 9.2.4 Japan Mucopolysaccharidosis II Forecast 2019-2025
  • 9.2.5 Southeast Asia Mucopolysaccharidosis II Forecast 2019-2025
  • 9.2.6 India Mucopolysaccharidosis II Forecast 2019-2025
• 9.3 Mucopolysaccharidosis II Market Trend (Product Type)
• 9.4 Mucopolysaccharidosis II Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Mucopolysaccharidosis II Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List